{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T10:59:59Z","timestamp":1768042799582,"version":"3.49.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T00:00:00Z","timestamp":1648252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T00:00:00Z","timestamp":1648252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Palliat Care"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Subcutaneous infusion (SC) or hypodermoclysis is an old perfusion technique that is often used off-label although it has been shown to be effective. Acetaminophen (paracetamol) subcutaneous injection is performed in some centers despite the lack of conclusive evidence on its effectiveness. This study aims to evaluate the efficacy of subcutaneous infusion of Acetaminophen in the treatment of pain and fever in geriatrics and in palliative care and to determine its safety profile and possible side effects.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Material and methods<\/jats:title>\n                <jats:p>This experimental study was conducted between 2018 and 2019 on adult patients in palliative care or in geriatrics in several hospitals and nursing homes in Lebanon. Primary outcomes were change in temperature; change in pain score on the numerical rating scale (NS) or on the Algoplus scale after 60\u2009min from the start of the infusion; and the appearance of local side effects at the infusion site. Changes in the various parameters at 30\u2009min and 180\u2009min were also evaluated as secondary outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Thirty-one patients were included in the study, with a total of 120 doses of acetaminophen. At 60\u2009min, the mean decrease in pain on the NS was 5.35 points, while the mean decrease in temperature was 0.79 degrees Celsius. At 60\u2009min, 75%, CI\u2009=\u2009[47.62-92.73] of the patients who received acetaminophen for pain and 66.67%, CI\u2009=\u2009[38.38-88.17] of those who received it for fever had clinically significant improvement. The overall effect of subcutaneous acetaminophen, defined as any clinically significant effect on pain or fever, was 70.97%, CI\u2009=\u2009[51.96-85.78]. The overall effect at 30\u2009min and at 180\u2009min was 23.33%, CI\u2009=\u2009[9.93-42.28] and 87.10%, CI\u2009=\u2009[70.17-96.37], respectively. The side effects reported 30\u2009min after the injection and observed after at least one of the doses were: local edema in 16 patients (51.61%), induration in one patient (3.23%), local pain in one patient (3.23%) and local heat in one patient (3.23%). At 180\u2009min, only 2 patients (6.45%) still had edema at the infusion site.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Subcutaneous administration of acetaminophen is effective and well tolerated in geriatric and palliative care patients. It is appropriate when no other route is available, especially for home-based care. Comparative studies are needed to allow the expansion of this practice.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12904-022-00934-3","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T22:03:02Z","timestamp":1648504982000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of efficacy and safety of subcutaneous acetaminophen in geriatrics and palliative care (APAPSUBQ)"],"prefix":"10.1186","volume":"21","author":[{"given":"Joe","family":"El Khoury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sani","family":"Hlais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Helou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Claire","family":"Mouhawej","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serge","family":"Barmo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Fadel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aline","family":"Tohme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,26]]},"reference":[{"key":"934_CR1","doi-asserted-by":"crossref","unstructured":"Morisson S, et al. M\u00e9dicaments administrables par voie sous-cutan\u00e9e en soins palliatifs : revue de la litt\u00e9rature et recommandations. M\u00e9decine Palliative: Soins de Support - Accompagnement - \u00c9thique. 2012;11:39\u201349.","DOI":"10.1016\/j.medpal.2011.03.003"},{"key":"934_CR2","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1191\/0269216304pm1006oa","volume":"19","author":"C Fonzo-Christe","year":"2005","unstructured":"Fonzo-Christe C, Vukasovic C, Wasilewski-Rasca A-F, Bonnabry P. Subcutaneous administration of drugs in the elderly: survey of practice and systematic literature review. Palliat Med. 2005;19:208\u201319.","journal-title":"Palliat Med"},{"key":"934_CR3","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.jpainsymman.2013.10.018","volume":"48","author":"L Bartz","year":"2014","unstructured":"Bartz L, et al. Subcutaneous administration of drugs in palliative care: results of a systematic observational study. J Pain Symptom Manag. 2014;48:540\u20137.","journal-title":"J Pain Symptom Manag"},{"key":"934_CR4","first-page":"1","volume":"15","author":"M Letizia","year":"2000","unstructured":"Letizia M, Shenk J, Jones TD. Intermittent subcutaneous injections for symptom control in hospice care: a retrospective investigation. Hosp J. 2000;15:1\u201311.","journal-title":"Hosp J"},{"key":"934_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00520-018-4368-x","volume":"27","author":"L Nijland","year":"2019","unstructured":"Nijland L, et al. Subcutaneous or intravenous opioid administration by patient-controlled analgesia in cancer pain: a systematic literature review. Support Care Cancer. 2019;27:33\u201342.","journal-title":"Support Care Cancer"},{"key":"934_CR6","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1177\/082585970301900403","volume":"19","author":"ST Tang","year":"2003","unstructured":"Tang ST, Mccorkle R. Determinants of congruence between the preferred and actual place of death for terminally ill cancer patients. J Palliat Care. 2003;19:230\u20137.","journal-title":"J Palliat Care"},{"key":"934_CR7","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1136\/bmjspcare-2012-000338","volume":"5","author":"E Arnold","year":"2015","unstructured":"Arnold E, Finucane AM, Oxenham D. Preferred place of death for patients referred to a specialist palliative care service. BMJ Support Palliat Care. 2015;5:294\u20136.","journal-title":"BMJ Support Palliat Care"},{"key":"934_CR8","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1191\/0269216305pm1050oa","volume":"19","author":"K Brazil","year":"2005","unstructured":"Brazil K, Howell D, Bedard M, Krueger P, Heidebrecht C. Preferences for place of care and place of death among informal caregivers of the terminally ill. Palliat Med. 2005;19:492\u20139.","journal-title":"Palliat Med"},{"key":"934_CR9","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1177\/0269216318773878","volume":"32","author":"S Healy","year":"2018","unstructured":"Healy S, Israel F, Charles M, Reymond L. Laycarers can confidently prepare and administer subcutaneous injections for palliative care patients at home: a randomized controlled trial. Palliat Med. 2018;32:1208\u201315.","journal-title":"Palliat Med"},{"key":"934_CR10","doi-asserted-by":"publisher","first-page":"390","DOI":"10.12968\/ijpn.2008.14.8.30774","volume":"14","author":"F Israel","year":"2008","unstructured":"Israel F, Reymond L, Slade G, Menadue S, Charles MA. Lay caregivers\u2019 perspectives on injecting subcutaneous medications at home. Int J Palliat Nurs. 2008;14:390\u20135.","journal-title":"Int J Palliat Nurs"},{"key":"934_CR11","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.jpainsymman.2016.04.009","volume":"52","author":"M Vidal","year":"2016","unstructured":"Vidal M, Hui D, Williams J, Bruera E. A prospective study of Hypodermoclysis performed by caregivers in the home setting. J Pain Symptom Manag. 2016;52:570\u2013574.e9.","journal-title":"J Pain Symptom Manag"},{"key":"934_CR12","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1177\/1049909113482514","volume":"31","author":"B Sheehy-Skeffington","year":"2014","unstructured":"Sheehy-Skeffington B, McLean S, Bramwell M, O\u2019Leary N, O\u2019Gorman A. Caregivers experiences of managing medications for palliative care patients at the end of life: a qualitative study. Am J Hosp Palliat Care. 2014;31:148\u201354.","journal-title":"Am J Hosp Palliat Care"},{"key":"934_CR13","doi-asserted-by":"publisher","first-page":"E40","DOI":"10.1097\/NCC.0000000000000098","volume":"37","author":"S Chellappan","year":"2014","unstructured":"Chellappan S, Ezhilarasu P, Gnanadurai A, George R, Christopher S. Can symptom relief be provided in the home to palliative care cancer patients by the primary caregivers? An Indian study. Cancer Nurs. 2014;37:E40\u20137.","journal-title":"Cancer Nurs"},{"key":"934_CR14","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1177\/0269216318772472","volume":"32","author":"BF Leheup","year":"2018","unstructured":"Leheup BF, Ducousso S, Picard S, Alluin R, Goetz C. Subcutaneous administration of paracetamol\u2014good local tolerability in palliative care patients: an observational study. Palliat Med. 2018;32:1216\u201321.","journal-title":"Palliat Med"},{"key":"934_CR15","doi-asserted-by":"crossref","unstructured":"Masson J, Leheup BF. Utilisation du parac\u00e9tamol par voie sous-cutan\u00e9e dans les unit\u00e9s de soins palliatifs en France. M\u00e9d Palliat. 2018;17:3\u20139.","DOI":"10.1016\/j.medpal.2017.10.003"},{"key":"934_CR16","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ejpain.2003.09.004","volume":"8","author":"F Salaffi","year":"2004","unstructured":"Salaffi F, Stancati A, Silvestri CA, Ciapetti A, Grassi W. Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. Eur J Pain. 2004;8:283\u201391.","journal-title":"Eur J Pain"},{"key":"934_CR17","doi-asserted-by":"crossref","unstructured":"Katz NP, Paillard FC, Ekman E. Determining the clinical importance of treatment benefits for interventions for painful orthopedic conditions. J Orthop Surg Res. 2015;10:24.","DOI":"10.1186\/s13018-014-0144-x"},{"key":"934_CR18","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1002\/ejp.844","volume":"20","author":"S Bonin-Guillaume","year":"2016","unstructured":"Bonin-Guillaume S, et al. Algoplus performance to detect pain in depressed and\/or demented old patients. Eur J Pain. 2016;20:1185\u201393.","journal-title":"Eur J Pain"},{"issue":"198","key":"934_CR19","first-page":"e1","volume":"15","author":"P Ratl","year":"2011","unstructured":"Ratl P, et al. Validation of an acute pain-behavior scale for older persons with inability to communicate verbally: Algoplus\u00ae. Eur J Pain. 2011;15(198):e1\u2013198.e10.","journal-title":"Eur J Pain"},{"key":"934_CR20","first-page":"CD007126","volume":"2016","author":"ED McNicol","year":"2016","unstructured":"McNicol ED, Ferguson MC, Haroutounian S, Carr DB, Schumann R. Single dose intravenous paracetamol or intravenous propacetamol for postoperative pain. Cochrane Database Syst Rev. 2016;2016:CD007126.","journal-title":"Cochrane Database Syst Rev"},{"key":"934_CR21","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/acem.12921","volume":"23","author":"B Sin","year":"2016","unstructured":"Sin B, Wai M, Tatunchak T, Motov SM. The use of intravenous acetaminophen for acute pain in the emergency department. Acad Emerg Med. 2016;23:543\u201353.","journal-title":"Acad Emerg Med"},{"key":"934_CR22","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12887-018-1166-z","volume":"18","author":"SJ Choi","year":"2018","unstructured":"Choi SJ, et al. The antipyretic efficacy and safety of propacetamol compared with dexibuprofen in febrile children: a multicenter, randomized, double-blind, comparative, phase 3 clinical trial. BMC Pediatr. 2018;18:201.","journal-title":"BMC Pediatr"},{"key":"934_CR23","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jclinane.2014.08.008","volume":"27","author":"J Kaur Makkar","year":"2015","unstructured":"Kaur Makkar J, Jain K, Bhatia N, Jain V, Mal Mithrawal S. Comparison of analgesic efficacy of paracetamol and tramadol for pain relief in active labor. J Clin Anesth. 2015;27:159\u201363.","journal-title":"J Clin Anesth"},{"key":"934_CR24","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jamaoto.2017.0238","volume":"143","author":"MA Tyler","year":"2017","unstructured":"Tyler MA, et al. Analgesic effects of intravenous acetaminophen vs placebo for endoscopic sinus surgery and postoperative pain: a randomized clinical trial. JAMA Otolaryngol Head Neck Surg. 2017;143:788\u201394.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"934_CR25","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.1001\/archinte.160.22.3486","volume":"160","author":"RB Lipton","year":"2000","unstructured":"Lipton RB, Baggish JS, Stewart WF, Codispoti JR, Fu M. Efficacy and safety of acetaminophen in the treatment of migraine: results of a randomized, double-blind, placebo-controlled, population-based study. Arch Intern Med. 2000;160:3486\u201392.","journal-title":"Arch Intern Med"},{"key":"934_CR26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2165\/00003495-200969010-00007","volume":"69","author":"ST Duggan","year":"2009","unstructured":"Duggan ST, Scott LJ. Intravenous Paracetamol (acetaminophen). Drugs. 2009;69:101\u201313.","journal-title":"Drugs"},{"key":"934_CR27","doi-asserted-by":"publisher","first-page":"673","DOI":"10.2217\/14796708.2.6.673","volume":"2","author":"O Malaise","year":"2007","unstructured":"Malaise O, Bruyere O, Reginster J-Y. Intravenous paracetamol: a review of efficacy and safety in therapeutic use. Future Neurol. 2007;2:673\u201388.","journal-title":"Future Neurol"},{"key":"934_CR28","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1460-9592.2008.02535.x","volume":"18","author":"K Allegaert","year":"2008","unstructured":"Allegaert K, Rayyan M, De Rijdt T, Van Beek F, Naulaers G. Hepatic tolerance of repeated intravenous paracetamol administration in neonates. Pediatr Anesth. 2008;18:388\u201392.","journal-title":"Pediatr Anesth"},{"key":"934_CR29","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s12028-016-0289-z","volume":"25","author":"DC Nichols","year":"2016","unstructured":"Nichols DC, Nadpara PA, Taylor PD, Brophy GM. Intravenous versus Oral acetaminophen for pain control in Neurocritical care patients. Neurocrit Care. 2016;25:400\u20136.","journal-title":"Neurocrit Care"},{"key":"934_CR30","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1001\/archpedi.162.11.1042","volume":"162","author":"LH Goldstein","year":"2008","unstructured":"Goldstein LH, Berlin M, Berkovitch M, Kozer E. Effectiveness of Oral vs rectal acetaminophen: a Meta-analysis. Arch Pediatr Adolesc Med. 2008;162:1042\u20136.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"934_CR31","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1097\/01.aco.0000245285.30282.70","volume":"19","author":"C Remy","year":"2006","unstructured":"Remy C, Marret E, Bonnet F. State of the art of paracetamol in acute pain therapy. Curr Opin Anaesthesiol. 2006;19:562\u20135.","journal-title":"Curr Opin Anaesthesiol"},{"key":"934_CR32","doi-asserted-by":"crossref","unstructured":"Durman G. Review of Cultural Differences in Chronic Pain. Am Med Stud Res J. 2019;6.","DOI":"10.15422\/amsrj.2019.08.008"},{"key":"934_CR33","doi-asserted-by":"publisher","first-page":"221","DOI":"10.5414\/CPP45221","volume":"45","author":"JF Duhamel","year":"2007","unstructured":"Duhamel JF, Le EG, Dalphin ML, Payen-Champenois C. Antipyretic efficacy and safety of a single intravenous administration of 15 mg\/kg paracetamol versus 30 mg\/kg propacetamol in children with acute fever due to infection. Int J Clin Pharmacol Ther. 2007;45:221\u20139.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"934_CR34","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1177\/0269216310383739","volume":"25","author":"L Radbruch","year":"2011","unstructured":"Radbruch L, Trottenberg P, Elsner F, Kaasa S, Caraceni A. Systematic review of the role of alternative application routes for opioid treatment for moderate to severe cancer pain: an EPCRC opioid guidelines project. Palliat Med. 2011;25:578\u201396.","journal-title":"Palliat Med"},{"key":"934_CR35","first-page":"419","volume":"15","author":"WH Chan","year":"1999","unstructured":"Chan WH, et al. Comparison of subcutaneous hydromorphone with intramuscular meperidine for immediate postoperative analgesia. Kaohsiung J Med Sci. 1999;15:419\u201327.","journal-title":"Kaohsiung J Med Sci"},{"key":"934_CR36","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1177\/107327480000700203","volume":"7","author":"RA Stevens","year":"2000","unstructured":"Stevens RA, Ghazi SM. Routes of opioid analgesic therapy in the management of cancer pain. Cancer Control. 2000;7:132\u201341.","journal-title":"Cancer Control"},{"key":"934_CR37","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S0885-3924(96)00329-6","volume":"13","author":"KA Nelson","year":"1997","unstructured":"Nelson KA, Glare PA, Walsh D, Groh ES. A prospective, within-patient, crossover study of continuous intravenous and subcutaneous morphine for chronic cancer pain. J Pain Symptom Manag. 1997;13:262\u20137.","journal-title":"J Pain Symptom Manag"},{"key":"934_CR38","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/J354v16n04_02","volume":"16","author":"RA Lugo","year":"2002","unstructured":"Lugo RA, Kern SE. Clinical pharmacokinetics of morphine. J Pain Palliat Care Pharmacother. 2002;16:5\u201318.","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"934_CR39","doi-asserted-by":"publisher","unstructured":"Quigley C. Hydromorphone for acute and chronic pain. Cochrane Database Syst Rev. 2002:CD003447. https:\/\/doi.org\/10.1002\/14651858.CD003447.","DOI":"10.1002\/14651858.CD003447"},{"key":"934_CR40","first-page":"CD012592","volume":"7","author":"PJ Wiffen","year":"2017","unstructured":"Wiffen PJ, Wee B, Derry S, Bell RF, Moore RA. Opioids for cancer pain - an overview of Cochrane reviews. Cochrane Database Syst Rev. 2017;7:CD012592.","journal-title":"Cochrane Database Syst Rev"},{"key":"934_CR41","first-page":"71","volume":"39","author":"C Matoses Chirivella","year":"2015","unstructured":"Matoses Chirivella C, et al. Subcutaneous drug administration in palliative care. Farm Hosp. 2015;39:71\u20139.","journal-title":"Farm Hosp"},{"key":"934_CR42","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/j.1533-2500.2012.00556.x","volume":"12","author":"NK Singla","year":"2012","unstructured":"Singla NK, et al. Plasma and cerebrospinal fluid pharmacokinetic parameters after single-dose Administration of Intravenous, Oral, or rectal acetaminophen. Pain Practice. 2012;12:523\u201332.","journal-title":"Pain Practice"},{"key":"934_CR43","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13063-019-3969-0","volume":"21","author":"M Vernant","year":"2020","unstructured":"Vernant M, et al. Intravenous versus subcutaneous route pharmacokinetics of paracetamol (acetaminophen) in palliative care patients: study protocol for a randomized trial (ParaSCIVPallia). Trials. 2020;21:138.","journal-title":"Trials"},{"key":"934_CR44","doi-asserted-by":"crossref","unstructured":"Petring OU, et al. Normal postoperative gastric emptying after orthopaedic surgery with spinal anaesthesia and i.m. ketorolac as the first postoperative analgesic. Br J Anaesth. 1995;74:257\u2013260.","DOI":"10.1093\/bja\/74.3.257"},{"key":"934_CR45","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1097\/00003246-200007000-00006","volume":"28","author":"M Berger","year":"2000","unstructured":"Berger M, et al. Intestinal absorption in patients after cardiac surgery. Crit Care Med. 2000;28:2217\u201323.","journal-title":"Crit Care Med"}],"container-title":["BMC Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-022-00934-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12904-022-00934-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12904-022-00934-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T22:06:35Z","timestamp":1648505195000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpalliatcare.biomedcentral.com\/articles\/10.1186\/s12904-022-00934-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,26]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["934"],"URL":"https:\/\/doi.org\/10.1186\/s12904-022-00934-3","relation":{},"ISSN":["1472-684X"],"issn-type":[{"value":"1472-684X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,26]]},"assertion":[{"value":"19 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board of H\u00f4tel-Dieu de France Hospital (CEHDF 1065). All methods were conducted in accordance with the ethical standards of the declaration of Helsinki. Each patient was informed of the course of the study and signed an informed consent form that was available in French and in Arabic for their inclusion and use of their data. When the patient was unable to communicate,\u00a0a legal representative was informed about the study and signed the consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}